Effect of a Basal/Pre-Meal Insulin Strategy (Detemir/Aspart) on Insulin Secretion and Action in Type 2 Diabetes

NCT00998335 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Long-acting bedtime insulin detemir (Levemir)
DRUG: Insulin detemir and pre-meal insulin aspart.

Sponsor

University of Florida

Collaborators

[object Object]
[object Object]